Secondly, how the SLC31A1 acts in glioma are still unclear, the analysis based on online data shows that the SLC31A1 influenced the progression of glioma, but whether and how it regulates the cuproptosis and other cell physiological activities in glioma is not validated, the further investigation is needed. This evidence concerns the gene SLC31A1 and central nervous system cancer.